English
简体中文
Total: £ 56.28
Published Date: 2026-01-20 | Pages: 108 | Tables: 112 | Pharma & Healthcare
The global Medical Liquid Embolic Agents market was valued at US$ 153 million in 2025 and is anticipated to reach US$ 253 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Liquid Embolic Agents competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Medical liquid embolic agents are specialized substances used in interventional radiology to block blood flow in targeted blood vessels, typically for treating vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, or tumors. These agents are delivered via a catheter and solidify or precipitate upon contact with blood or tissue, creating a durable embolization effect. Common types include cyanoacrylate glues, ethylene-vinyl alcohol copolymer (EVOH), and onyx-based systems, which vary in composition, viscosity, and application methods. They offer a minimally invasive treatment option, reducing the need for open surgery while providing precise vascular occlusion to manage bleeding or cut off blood supply to abnormal tissues.
The North American market for Medical Liquid Embolic Agents is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Medical Liquid Embolic Agents is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Medical Liquid Embolic Agents include Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Medical Liquid Embolic Agents market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Liquid Embolic Agents. The Medical Liquid Embolic Agents market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Liquid Embolic Agents market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Liquid Embolic Agents manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic
Balt Group
Johnson & Johnson
Meril Life
BlackSwan Vascular
Success Bio-Tech
Segment by Type
EVOH-Based
Diluted Cyanoacrylate
Others
by Application
Brain Arterio-Venous Malformations (bAVM)
Tumor Embolization
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Liquid Embolic Agents manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Medical Liquid Embolic Agents sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Medical Liquid Embolic Agents Market Overview
1.1 Product Definition
1.2 Medical Liquid Embolic Agents by Type
1.2.1 Global Medical Liquid Embolic Agents Market Value by Type: 2025 vs 2032
1.2.2 EVOH-Based
1.2.3 Diluted Cyanoacrylate
1.2.4 Others
1.3 Medical Liquid Embolic Agents by Application
1.3.1 Global Medical Liquid Embolic Agents Market Value by Application: 2025 vs 2032
1.3.2 Brain Arterio-Venous Malformations (bAVM)
1.3.3 Tumor Embolization
1.3.4 Others
1.4 Global Medical Liquid Embolic Agents Market Size Estimates and Forecasts
1.4.1 Global Medical Liquid Embolic Agents Revenue 2021–2032
1.4.2 Global Medical Liquid Embolic Agents Sales 2021–2032
1.4.3 Global Medical Liquid Embolic Agents Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Medical Liquid Embolic Agents Market Competition by Manufacturers
2.1 Global Medical Liquid Embolic Agents Sales Market Share by Manufacturers (2021–2026)
2.2 Global Medical Liquid Embolic Agents Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Medical Liquid Embolic Agents Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Medical Liquid Embolic Agents, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Medical Liquid Embolic Agents, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Medical Liquid Embolic Agents, Product Types and Applications
2.7 Global Key Manufacturers of Medical Liquid Embolic Agents, Date of Entry into the Industry
2.8 Global Medical Liquid Embolic Agents Market Competitive Situation and Trends
2.8.1 Global Medical Liquid Embolic Agents Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Medical Liquid Embolic Agents Players Market Share by Revenue
2.8.3 Global Medical Liquid Embolic Agents Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Liquid Embolic Agents Market Scenario by Region
3.1 Global Medical Liquid Embolic Agents Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Liquid Embolic Agents Sales by Region: 2021–2032
3.2.1 Global Medical Liquid Embolic Agents Sales by Region: 2021–2026
3.2.2 Global Medical Liquid Embolic Agents Sales by Region: 2027–2032
3.3 Global Medical Liquid Embolic Agents Revenue by Region: 2021–2032
3.3.1 Global Medical Liquid Embolic Agents Revenue by Region: 2021–2026
3.3.2 Global Medical Liquid Embolic Agents Revenue by Region: 2027–2032
3.4 North America Medical Liquid Embolic Agents Market Facts & Figures by Country
3.4.1 North America Medical Liquid Embolic Agents Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Medical Liquid Embolic Agents Sales by Country (2021–2032)
3.4.3 North America Medical Liquid Embolic Agents Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Liquid Embolic Agents Market Facts & Figures by Country
3.5.1 Europe Medical Liquid Embolic Agents Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Medical Liquid Embolic Agents Sales by Country (2021–2032)
3.5.3 Europe Medical Liquid Embolic Agents Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Liquid Embolic Agents Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Liquid Embolic Agents Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Medical Liquid Embolic Agents Sales by Region (2021–2032)
3.6.3 Asia Pacific Medical Liquid Embolic Agents Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Liquid Embolic Agents Market Facts & Figures by Country
3.7.1 Latin America Medical Liquid Embolic Agents Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Medical Liquid Embolic Agents Sales by Country (2021–2032)
3.7.3 Latin America Medical Liquid Embolic Agents Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Liquid Embolic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Liquid Embolic Agents Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Medical Liquid Embolic Agents Sales by Country (2021–2032)
3.8.3 Middle East and Africa Medical Liquid Embolic Agents Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Liquid Embolic Agents Sales by Type (2021–2032)
4.1.1 Global Medical Liquid Embolic Agents Sales by Type (2021–2026)
4.1.2 Global Medical Liquid Embolic Agents Sales by Type (2027–2032)
4.1.3 Global Medical Liquid Embolic Agents Sales Market Share by Type (2021–2032)
4.2 Global Medical Liquid Embolic Agents Revenue by Type (2021–2032)
4.2.1 Global Medical Liquid Embolic Agents Revenue by Type (2021–2026)
4.2.2 Global Medical Liquid Embolic Agents Revenue by Type (2027–2032)
4.2.3 Global Medical Liquid Embolic Agents Revenue Market Share by Type (2021–2032)
4.3 Global Medical Liquid Embolic Agents Price by Type (2021–2032)
5 Segment by Application
5.1 Global Medical Liquid Embolic Agents Sales by Application (2021–2032)
5.1.1 Global Medical Liquid Embolic Agents Sales by Application (2021–2026)
5.1.2 Global Medical Liquid Embolic Agents Sales by Application (2027–2032)
5.1.3 Global Medical Liquid Embolic Agents Sales Market Share by Application (2021–2032)
5.2 Global Medical Liquid Embolic Agents Revenue by Application (2021–2032)
5.2.1 Global Medical Liquid Embolic Agents Revenue by Application (2021–2026)
5.2.2 Global Medical Liquid Embolic Agents Revenue by Application (2027–2032)
5.2.3 Global Medical Liquid Embolic Agents Revenue Market Share by Application (2021–2032)
5.3 Global Medical Liquid Embolic Agents Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Medical Liquid Embolic Agents Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Medical Liquid Embolic Agents Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Balt Group
6.2.1 Balt Group Company Information
6.2.2 Balt Group Description and Business Overview
6.2.3 Balt Group Medical Liquid Embolic Agents Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Balt Group Medical Liquid Embolic Agents Product Portfolio
6.2.5 Balt Group Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Medical Liquid Embolic Agents Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Johnson & Johnson Medical Liquid Embolic Agents Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Meril Life
6.4.1 Meril Life Company Information
6.4.2 Meril Life Description and Business Overview
6.4.3 Meril Life Medical Liquid Embolic Agents Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Meril Life Medical Liquid Embolic Agents Product Portfolio
6.4.5 Meril Life Recent Developments/Updates
6.5 BlackSwan Vascular
6.5.1 BlackSwan Vascular Company Information
6.5.2 BlackSwan Vascular Description and Business Overview
6.5.3 BlackSwan Vascular Medical Liquid Embolic Agents Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BlackSwan Vascular Medical Liquid Embolic Agents Product Portfolio
6.5.5 BlackSwan Vascular Recent Developments/Updates
6.6 Success Bio-Tech
6.6.1 Success Bio-Tech Company Information
6.6.2 Success Bio-Tech Description and Business Overview
6.6.3 Success Bio-Tech Medical Liquid Embolic Agents Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Success Bio-Tech Medical Liquid Embolic Agents Product Portfolio
6.6.5 Success Bio-Tech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Liquid Embolic Agents Industry Chain Analysis
7.2 Medical Liquid Embolic Agents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Liquid Embolic Agents Production Mode & Process Analysis
7.4 Medical Liquid Embolic Agents Sales and Marketing
7.4.1 Medical Liquid Embolic Agents Sales Channels
7.4.2 Medical Liquid Embolic Agents Distributors
7.5 Medical Liquid Embolic Agents Customer Analysis
8 Medical Liquid Embolic Agents Market Dynamics
8.1 Medical Liquid Embolic Agents Industry Trends
8.2 Medical Liquid Embolic Agents Market Drivers
8.3 Medical Liquid Embolic Agents Market Challenges
8.4 Medical Liquid Embolic Agents Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Medical Liquid Embolic Agents Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Medical Liquid Embolic Agents Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Medical Liquid Embolic Agents Market Competitive Situation by Manufacturers in 2025
Table 4. Global Medical Liquid Embolic Agents Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Medical Liquid Embolic Agents Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Medical Liquid Embolic Agents Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Medical Liquid Embolic Agents Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Medical Liquid Embolic Agents, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Medical Liquid Embolic Agents, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Medical Liquid Embolic Agents, Product Types and Applications
Table 12. Global Key Manufacturers of Medical Liquid Embolic Agents, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medical Liquid Embolic Agents Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Liquid Embolic Agents Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medical Liquid Embolic Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Medical Liquid Embolic Agents Sales by Region (K Dose), 2021–2026
Table 18. Global Medical Liquid Embolic Agents Sales Market Share by Region (2021–2026)
Table 19. Global Medical Liquid Embolic Agents Sales by Region (K Dose), 2027–2032
Table 20. Global Medical Liquid Embolic Agents Sales Market Share by Region (2027–2032)
Table 21. Global Medical Liquid Embolic Agents Revenue by Region (US$ Million), 2021–2026
Table 22. Global Medical Liquid Embolic Agents Revenue Market Share by Region (2021–2026)
Table 23. Global Medical Liquid Embolic Agents Revenue by Region (US$ Million), 2027–2032
Table 24. Global Medical Liquid Embolic Agents Revenue Market Share by Region (2027–2032)
Table 25. North America Medical Liquid Embolic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Medical Liquid Embolic Agents Sales by Country (K Dose), 2021–2026
Table 27. North America Medical Liquid Embolic Agents Sales by Country (K Dose), 2027–2032
Table 28. North America Medical Liquid Embolic Agents Revenue by Country (US$ Million), 2021–2026
Table 29. North America Medical Liquid Embolic Agents Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Medical Liquid Embolic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Medical Liquid Embolic Agents Sales by Country (K Dose), 2021–2026
Table 32. Europe Medical Liquid Embolic Agents Sales by Country (K Dose), 2027–2032
Table 33. Europe Medical Liquid Embolic Agents Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Medical Liquid Embolic Agents Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Medical Liquid Embolic Agents Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Medical Liquid Embolic Agents Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Medical Liquid Embolic Agents Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Medical Liquid Embolic Agents Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Medical Liquid Embolic Agents Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Medical Liquid Embolic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Medical Liquid Embolic Agents Sales by Country (K Dose), 2021–2026
Table 42. Latin America Medical Liquid Embolic Agents Sales by Country (K Dose), 2027–2032
Table 43. Latin America Medical Liquid Embolic Agents Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Medical Liquid Embolic Agents Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Medical Liquid Embolic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Medical Liquid Embolic Agents Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Medical Liquid Embolic Agents Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Medical Liquid Embolic Agents Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Medical Liquid Embolic Agents Revenue by Country (US$ Million), 2027–2032
Table 50. Global Medical Liquid Embolic Agents Sales (K Dose) by Type (2021–2026)
Table 51. Global Medical Liquid Embolic Agents Sales (K Dose) by Type (2027–2032)
Table 52. Global Medical Liquid Embolic Agents Sales Market Share by Type (2021–2026)
Table 53. Global Medical Liquid Embolic Agents Sales Market Share by Type (2027–2032)
Table 54. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Medical Liquid Embolic Agents Revenue Market Share by Type (2021–2026)
Table 57. Global Medical Liquid Embolic Agents Revenue Market Share by Type (2027–2032)
Table 58. Global Medical Liquid Embolic Agents Price (US$/Dose) by Type (2021–2026)
Table 59. Global Medical Liquid Embolic Agents Price (US$/Dose) by Type (2027–2032)
Table 60. Global Medical Liquid Embolic Agents Sales (K Dose) by Application (2021–2026)
Table 61. Global Medical Liquid Embolic Agents Sales (K Dose) by Application (2027–2032)
Table 62. Global Medical Liquid Embolic Agents Sales Market Share by Application (2021–2026)
Table 63. Global Medical Liquid Embolic Agents Sales Market Share by Application (2027–2032)
Table 64. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Medical Liquid Embolic Agents Revenue Market Share by Application (2021–2026)
Table 67. Global Medical Liquid Embolic Agents Revenue Market Share by Application (2027–2032)
Table 68. Global Medical Liquid Embolic Agents Price (US$/Dose) by Application (2021–2026)
Table 69. Global Medical Liquid Embolic Agents Price (US$/Dose) by Application (2027–2032)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Medtronic Medical Liquid Embolic Agents Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Balt Group Company Information
Table 76. Balt Group Description and Business Overview
Table 77. Balt Group Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Balt Group Medical Liquid Embolic Agents Product
Table 79. Balt Group Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Johnson & Johnson Medical Liquid Embolic Agents Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Meril Life Company Information
Table 86. Meril Life Description and Business Overview
Table 87. Meril Life Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Meril Life Medical Liquid Embolic Agents Product
Table 89. Meril Life Recent Developments/Updates
Table 90. BlackSwan Vascular Company Information
Table 91. BlackSwan Vascular Description and Business Overview
Table 92. BlackSwan Vascular Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. BlackSwan Vascular Medical Liquid Embolic Agents Product
Table 94. BlackSwan Vascular Recent Developments/Updates
Table 95. Success Bio-Tech Company Information
Table 96. Success Bio-Tech Description and Business Overview
Table 97. Success Bio-Tech Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Success Bio-Tech Medical Liquid Embolic Agents Product
Table 99. Success Bio-Tech Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Medical Liquid Embolic Agents Distributors List
Table 103. Medical Liquid Embolic Agents Customers List
Table 104. Medical Liquid Embolic Agents Market Trends
Table 105. Medical Liquid Embolic Agents Market Drivers
Table 106. Medical Liquid Embolic Agents Market Challenges
Table 107. Medical Liquid Embolic Agents Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medical Liquid Embolic Agents
Figure 2. Global Medical Liquid Embolic Agents Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Medical Liquid Embolic Agents Market Share by Type: 2025 & 2032
Figure 4. EVOH-Based Product Picture
Figure 5. Diluted Cyanoacrylate Product Picture
Figure 6. Others Product Picture
Figure 7. Global Medical Liquid Embolic Agents Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Medical Liquid Embolic Agents Market Share by Application: 2025 & 2032
Figure 9. Brain Arterio-Venous Malformations (bAVM)
Figure 10. Tumor Embolization
Figure 11. Others
Figure 12. Global Medical Liquid Embolic Agents Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Medical Liquid Embolic Agents Market Size (US$ Million), 2021–2032
Figure 14. Global Medical Liquid Embolic Agents Sales (K Dose), 2021–2032
Figure 15. Global Medical Liquid Embolic Agents Average Price (US$/Dose), 2021–2032
Figure 16. Medical Liquid Embolic Agents Report Years Considered
Figure 17. Medical Liquid Embolic Agents Sales Share by Manufacturers in 2025
Figure 18. Global Medical Liquid Embolic Agents Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Medical Liquid Embolic Agents Players: Market Share by Revenue in Medical Liquid Embolic Agents in 2025
Figure 20. Medical Liquid Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Medical Liquid Embolic Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Medical Liquid Embolic Agents Sales Market Share by Country (2021–2032)
Figure 23. North America Medical Liquid Embolic Agents Revenue Market Share by Country (2021–2032)
Figure 24. United States Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Medical Liquid Embolic Agents Sales Market Share by Country (2021–2032)
Figure 27. Europe Medical Liquid Embolic Agents Revenue Market Share by Country (2021–2032)
Figure 28. Germany Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Medical Liquid Embolic Agents Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Medical Liquid Embolic Agents Revenue Market Share by Region (2021–2032)
Figure 35. China Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Medical Liquid Embolic Agents Sales Market Share by Country (2021–2032)
Figure 43. Latin America Medical Liquid Embolic Agents Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Medical Liquid Embolic Agents Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Medical Liquid Embolic Agents Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Medical Liquid Embolic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Medical Liquid Embolic Agents by Type (2021–2032)
Figure 54. Global Revenue Market Share of Medical Liquid Embolic Agents by Type (2021–2032)
Figure 55. Global Medical Liquid Embolic Agents Price (US$/Dose) by Type (2021–2032)
Figure 56. Global Sales Market Share of Medical Liquid Embolic Agents by Application (2021–2032)
Figure 57. Global Revenue Market Share of Medical Liquid Embolic Agents by Application (2021–2032)
Figure 58. Global Medical Liquid Embolic Agents Price (US$/Dose) by Application (2021–2032)
Figure 59. Medical Liquid Embolic Agents Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
